Syunsuke Yamamoto

Taisho Pharmaceutical (Japan)

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (4)

Tetsuya Nagata

Tokyo Medical and Dental University

JAPAN

View details

Kensuke Ihara

Tokyo Medical and Dental University

JAPAN

View details

Fumika Sakaue

Research Assistant Professor

Tokyo Medical and Dental University

JAPAN

View details

Takuya Kuroda

Chief

National Institute of Health Sciences

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Syunsuke Yamamoto

Research Interests

Explore related searches

Contact this professor

Articles (10)

AAV delivery of GBA1 suppresses α-synuclein accumulation in Parkinson’s disease models and restores functions in Gaucher’s disease models

Pharmacokinetics and protein binding of cholesterol-conjugated heteroduplex oligonucleotide

Using qPCR and ddPCR to study biodistribution of cell therapy products: a multi-site evaluation

Heteroduplex oligonucleotide technology boosts oligonucleotide splice switching activity of morpholino oligomers in a Duchenne muscular dystrophy mouse model.

DMPK perspective on quantitative model analysis for chimeric antigen receptor cell therapy: Advances and challenges

Advanced translational PBPK model for transferrin receptor-mediated drug delivery to the brain.

Novel Cell Quantification Method Using a Single Surrogate Calibration Curve Across Various Biological Samples

Preferential delivery of lipid-ligand conjugated DNA/RNA heteroduplex oligonucleotide to ischemic brain in hyperacute stage

Biodistribution and delivery of oligonucleotide therapeutics to the central nervous system: Advances, challenges, and future perspectives

Quantitative Model Analysis and Simulation of Pharmacokinetics and<i>Malat1</i>RNA Knockdown Effect After Systemic Administration of Cholesterol-conjugated DNA/RNA Heteroduplex Oligonucleotide Crossing Blood-Brain Barrier of Mice

Collaborators (4)

Tetsuya Nagata

Kensuke Ihara

Fumika Sakaue

Takuya Kuroda

Make your next move.